Episode
The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D.
- Podcast
- Answers from the Lab
- Published
- Aug 14, 2025
- Duration seconds
- 680
- Processing state
not_requested- Canonical source
- https://share.transistor.fm/s/0c68b995
Actions
POST https://stenobird.com/v1/public/podcasts/answers-from-the-lab-870296/episodes/the-promise-challenges-and-global-impact-of-ai-tools-bill-morice-m-d-ph-d/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/answers-from-the-lab-870296/the-promise-challenges-and-global-impact-of-ai-tools-bill-morice-m-d-ph-d.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Published August 14, 2025 In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D. , CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare. Together, they explore: Applications of AI tools in clinical diagnostics to identify dementia, cardiovascular conditions, and parasites. Ethical considerations, including global disparities in access to AI tools and environmental impacts. Resources Use of artificial intelligence and digital slide scanning for detection of intestinal protozoa in trichrome-stained stool specimens Mayo Clinic's AI tool identifies 9 dementia types, including Alzheimer's, with one scan AI computing power is splitting the world into haves and have-nots - The New York Times